Drug Pipeline

PARP inhibitor Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
1
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 2/3
1
Phase 2
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07472140 PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in… Ovarian Cancer Recruiting
Phase 2
NCT06145308 Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular… Salivary Gland Carcinoma Recruiting
Phase 1/2
NCT06502691 [18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in… Anatomic Stage IV Breast Cancer AJCC v8 Recruiting
Sponsors Running PARP inhibitor Trials
Peking Union Medical College (1) University of Washington (1) N.N. Alexandrov National Cancer Centre (1)
Disease Areas
Breast Cancer (1) Ovarian Cancer (1)
Get alerts when PARP inhibitor trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free